Ramirez PT, Frumovitz M., Bodurka DC, Sun CC, Levenback C.: Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol2004;95:133—138.
2.
Kim YB, Holschneider CH, Ghosh K., Neiberg RK, Montz FJ: Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer1997;79: 320—327.
3.
Munstedt K., Grant P., Woenckhaus J., Roth R., Tinneberg HR: Cancer of the endometrium: current aspects of diagnostics and treatment. World J Surg Oncol2004;2:24.
4.
Berman ML, Balloon SC, Lagasse LD, Watring WG: Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol1980;136:679—688.
5.
Kaku T., Yoshikawa H., Tsuda H., et al: Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett2001;167:39—48.
6.
Patsner B.: Endometrial cancer in women 45 years of age or younger. Eur J Gynaecol Oncol2000;21:249—250.
7.
Yahata T., Fujita K., Aoki Y., Tanaka K.: Long-term conservative therapy for endometrial adenocarcinoma in young women . Hum Reprod2006;21:1070—1075.
